Psyence Biomedical (PBM) Current Assets (2022 - 2026)

Psyence Biomedical has reported Current Assets for 5 years, with the latest figure at $9.1 million in Q1 2026.

• On a quarterly basis, Current Assets rose 38.87% year-over-year to $9.1 million in Q1 2026; TTM through Mar 2026 was $9.1 million, a 38.87% increase from a year earlier, with the FY2026 full-year figure at $9.1 million, up 38.87% from the prior year.
• Current Assets was $9.1 million for Q1 2026 at Psyence Biomedical, up from $7.6 million in the prior quarter.
• The five-year high for Current Assets was $9.1 million in Q1 2026, with the low at $162516.0 in Q3 2023.
• Average Current Assets over 5 years is $3.8 million, with a median of $1.9 million recorded in 2024.
• The largest YoY upside for Current Assets was 1280.4% in 2024 against a maximum downside of 0.33% in 2024.
• Over 5 years, Current Assets stood at $1.2 million in 2022, then sank by 86.52% to $162516.0 in 2023, then surged by 1280.4% to $2.2 million in 2024, then soared by 240.09% to $7.6 million in 2025, then advanced by 19.41% to $9.1 million in 2026.
• The last three Current Assets figures came in at $9.1 million (Q1 2026), $7.6 million (Q3 2025), and $6.6 million (Q1 2025), per Business Quant data.